Fig. 3
From: Identification of CD159A as a prognostic and immune biomarker in kidney renal clear cell carcinoma
Correlation analysis between CD159A and clinical characteristics of KIRC. Correlation between CD159A expression and clinical characteristics of KIRC, including A age, B pathologic M stage, C gender, D histologic grade, and E the risk factors for CD159A mRNA high expression shown in the forest plot based on logistic regression analysis. F ROC analysis of CD159A in KIRC. Survival map and Kaplan–Meier curves of the correlation between CD159A mRNA levels in G OS and H RFS. *p < 0.05, ***p < 0.001.
